SEC / FDA / FTC Regulatory Watch2026-11-02Infant formula limits, a $200 million crypto complaint, and nine companies asked how they price — October 27–November 2, 2026A sourced digest of the twenty-four SEC, FDA, and FTC developments from October 27 to November 2, 2026, with the parties, procedural status, money at issue, and the deadlines to calendar.
SEC / FDA / FTC Regulatory Watch2026-10-26Examiners' priority list, a $106.8 million judgment, and the first antisense hepatitis B drug — October 20–26, 2026A sourced digest of the twenty-two SEC, FDA, and FTC developments from October 20–26, 2026, with the parties, procedural status, money at issue, and the deadlines to calendar.1
SEC / FDA / FTC Regulatory Watch2026-10-19Cross-trading's deadline, an approval built on another approval, and 18.5 million tickets — October 13–19, 2026A sourced digest of the twenty-one SEC, FDA, and FTC developments from October 13–19, 2026, with the parties, procedural status, money at issue, and the deadlines to calendar.1
SEC / FDA / FTC Regulatory Watch2026-10-12Cross-trading at the SEC, two cherry-picking cases, and the FTC's price-transparency push — October 6–12, 2026A sourced digest of the 29 SEC, FDA, and FTC developments from October 6–12, 2026, with the parties, procedural status, money at issue, and the deadlines to calendar.1
SEC / FDA / FTC Regulatory Watch2026-10-05Crypto custody, private-market access, and the FTC's first Robinson-Patman settlement in a generation — September 29–October 5, 2026A sourced digest of the 38 SEC, FDA, and FTC developments from September 29–October 5, 2026, with the parties, procedural status, money at issue, and the deadlines to calendar.
SEC / FDA / FTC Regulatory Watch2026-09-28SEC control failures, FDA's nonclinical-testing rule, and a $127M truck-leasing Ponzi — September 22–28, 2026A sourced digest of the twenty-five SEC, FDA, and FTC actions from September 22–28, 2026, with the parties, the procedural status, the money at issue, and the dates to calendar.2
SEC / FDA / FTC Regulatory Watch2026-09-21SEC tokenized-stock exemption, FDA first-in-class approvals, and a $225M Amway order — September 15–21, 2026A sourced digest of fifteen SEC, FDA and FTC actions from September 15–21, 2026, with the parties, the procedural status, the money at issue, and the dates to calendar.3
SEC / FDA / FTC Regulatory Watch2026-09-14SEC Ponzi actions, FDA dual approvals, and FTC $12M processor ban — September 8–14, 2026A concise, calendar-ready digest of eight SEC, FDA, and FTC developments from September 8–14, 2026, with affected parties, procedural status, operational implications, and original agency links.31
SEC / FDA / FTC Regulatory Watch2026-09-07SEC subpoenas, FDA approvals, and FTC pricing deadline — September 1–7, 2026A concise, calendar-ready digest of 12 SEC, FDA, and FTC developments from September 1–7, 2026, with affected parties, procedural status, operational implications, and original agency links.
SEC / FDA / FTC Regulatory Watch2026-08-31SEC false adviser filings, FDA approvals, and FTC final orders - August 24-30, 2026A sourced weekly digest of 18 SEC, FDA, and FTC developments from August 24-30, 2026, with procedural status, operational implications, and calendar-ready actions.1
SEC / FDA / FTC Regulatory Watch2026-08-24Crypto rulebook, Genglycos, and FTC pricing scrutiny — August 17–23, 2026A sourced weekly digest of SEC crypto rulemaking and enforcement, FDA approvals and AI-device policy, and FTC settlements, injunctions, and personalized-pricing scrutiny from August 17–23, 2026.
SEC / FDA / FTC Regulatory Watch2026-08-17SEC fraud docket, FDA animal-drug EUA, and FTC consumer redress (August 10-16, 2026)This week's digest separates five SEC fraud complaints, FDA's defined Simparica TRIO emergency authorization, and FTC actions that moved from a temporary halt to consumer redress payments.